At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Understanding Quality of Life in High Digital Device Users Who Are Treated With Systane Hydration PF
In Brief
A Phase 4 clinical trial evaluating Systane Hydration PF for Dry Eye. Completed, enrolled 30 participants across 1 site.
Detailed Summary
Systane Hydration PF is a recently released preservative-free artificial tear that is able to supplement the ocular surface's moisture while simultaneously soothing the eye. While Systane Hydration PF should in theory improve the symptoms and subsequently the quality of life of patients who have DES, this clinical application has yet to be tested. This drop furthermore is available in both unit-dose and multi-dose options; however, it is unclear if patient perceive a difference between the two dispensing methods. Therefore, the primary purpose of this study is to recruit patients who have DES and to treat them with Systane Hydration PF and determine how regular use of this drop impacts a patient's ocular surface symptoms and overall quality of life. This study will secondarily compare the two dispensing methods to determine if patients prefer one method over the other.
Study Details
Timeline
Interventions
This is an over-the-counter preservative free artificial tear that can be purchased at most retail stores and pharmacies.